| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/24/2003 | EP1347063A1 Multiple genes relevant for the characterisation, diagnosis and manipulation of stroke |
| 09/24/2003 | EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 09/24/2003 | EP1347054A1 TAP-70, a novel marker for epithelial tumors |
| 09/24/2003 | EP1347053A1 Process for producing rfrp |
| 09/24/2003 | EP1347052A1 Guanosine triphosphate (gtp) binding protein-coupled receptor protein, bg37 |
| 09/24/2003 | EP1347050A1 Novel potassium channel |
| 09/24/2003 | EP1347049A1 Novel potassium channel |
| 09/24/2003 | EP1347047A2 Mice lacking inward-rectifying potassium channel Kir6.1 |
| 09/24/2003 | EP1347046A1 Full-length cDNA sequences |
| 09/24/2003 | EP1346999A2 Human secreted protein |
| 09/24/2003 | EP1346998A1 Equine arteritis virus vaccine |
| 09/24/2003 | EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage |
| 09/24/2003 | EP1346730A1 Pretargeting methods and novel pretargeting conjugates |
| 09/24/2003 | EP1346727A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 09/24/2003 | EP1346230A2 Screening method based on tsap6 binding partners |
| 09/24/2003 | EP1346228A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 09/24/2003 | EP1346226A1 Screening method based on siah-numb interaction |
| 09/24/2003 | EP1346218A1 Tripeptide of fc gama riia |
| 09/24/2003 | EP1346217A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 09/24/2003 | EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 09/24/2003 | EP1346060A1 Novel molecules of the card-related protein family and used thereof |
| 09/24/2003 | EP1346058A2 Adenoviral systems and the uses thereof |
| 09/24/2003 | EP1346056A1 Methods for the production of multimeric proteins, and related compositions |
| 09/24/2003 | EP1346050A2 Regulators of fungal gene expression |
| 09/24/2003 | EP1346049A2 EFFICIENT EXPRESSION OF i PLASMODIUM /i APICAL MEMBRANE ANTIGEN 1 IN YEAST CELLS |
| 09/24/2003 | EP1346048A1 Mycoplasma spp. a39 |
| 09/24/2003 | EP1346047A2 Yeasts transformed by genes enhancing their cold stress tolerance |
| 09/24/2003 | EP1346045A1 Human protooncogene and protein encoded therein |
| 09/24/2003 | EP1346043A2 Compositions and methods relating to lung specific genes and proteins |
| 09/24/2003 | EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 09/24/2003 | EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/24/2003 | EP1346040A2 Novel nucleic acids and polypeptides |
| 09/24/2003 | EP1346039A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 09/24/2003 | EP1346038A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/24/2003 | EP1346036A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 09/24/2003 | EP1346035A2 Plant transcription factors |
| 09/24/2003 | EP1345966A2 Crystallized cytoplasmic tie2 receptor tyrosine kinase domain and method of determining and designing modulators of the same |
| 09/24/2003 | EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 09/24/2003 | EP1345964A2 Polypeptides having a triggering nk activity and biological applications |
| 09/24/2003 | EP1345963A2 Isolation of purified tgf- 1 and tgf- 2 from bone tissue |
| 09/24/2003 | EP1345962A2 Methods and compositions relating to cardiac-specific nuclear regulatory factors |
| 09/24/2003 | EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 09/24/2003 | EP1345960A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau-r4 |
| 09/24/2003 | EP1345959A2 Membrane scaffold proteins |
| 09/24/2003 | EP1345958A1 Antibodies, peptides, analogs and uses thereof |
| 09/24/2003 | EP1345743A1 Electroprocessed collagen |
| 09/24/2003 | EP1345623A2 Immunogenic proteoliposomes, and uses thereof |
| 09/24/2003 | EP1345622A2 Eiav chimeric vaccine and diagnostic |
| 09/24/2003 | EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 09/24/2003 | EP1206482B1 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 09/24/2003 | EP1123109B1 Contulakin-g, analogs thereof and uses therefor |
| 09/24/2003 | EP1049709B1 Antimicrobial peptides |
| 09/24/2003 | EP0982988B1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| 09/24/2003 | EP0975671B1 Method of chromatographically purifying or fractionating von willebrand factor from a vwf-containing starter material |
| 09/24/2003 | EP0975359B1 Use of compounds binding a cytoplasmic dipeptidase for the potentiation of the immune response |
| 09/24/2003 | EP0909388B1 Immunological assay for spongiform encephalopathies |
| 09/24/2003 | EP0847278B1 Analogs of parathyroid hormone |
| 09/24/2003 | EP0833847B1 Crystals of fragments of cd40 ligand and their use |
| 09/24/2003 | EP0535216B1 Dna encoding mammalian phosphodiesterases |
| 09/24/2003 | CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses |
| 09/24/2003 | CN1444657A Expression vector using for animal cell |
| 09/24/2003 | CN1444655A Preparation of recombinant protein in prokaryotic host cell |
| 09/24/2003 | CN1444652A Mammalian receptor proteins, related regents and methods |
| 09/24/2003 | CN1444603A Low oxygen affinity mutant hemoglobins |
| 09/24/2003 | CN1444602A Human receptor proteins, related reagents and methods |
| 09/24/2003 | CN1444601A Regulating lipid levels via the Zmaxl or HBM gene |
| 09/24/2003 | CN1444600A Use of ADNF polypeptides for enhancing learning and memory |
| 09/24/2003 | CN1444599A Novel compounds |
| 09/24/2003 | CN1444598A Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of immune response to amyloid beta and amyloid deposits |
| 09/24/2003 | CN1443850A Method for preparing recombinant human CTLA4 extracellular region protein, and obtained product and application |
| 09/24/2003 | CN1443849A Preparation method of reversible photochromic biliprotein |
| 09/24/2003 | CN1443776A Recombinant human interleukin-4, its code nucleic acid and its application |
| 09/24/2003 | CN1443775A Leptospira outer membrane protein and its code sequence |
| 09/24/2003 | CN1443774A Leptospira hemolysin and its code sequence |
| 09/24/2003 | CN1443773A Leptospira pathogenic related protein and its code squence |
| 09/24/2003 | CN1443772A Narcissus seed glycopeptide and its application |
| 09/24/2003 | CN1443756A Bicyclic aromatic compound |
| 09/24/2003 | CN1122108C Immunogenic peptides of foot and mouth disease viruses |
| 09/24/2003 | CN1122107C Intracellular antifreeze polypeptide and nucleic acids |
| 09/24/2003 | CN1122105C Novel method viruses, anti viral compounds and novel methods of making vaccines |
| 09/23/2003 | US6624344 Transformation of cotton plants |
| 09/23/2003 | US6624343 Isolated polynucleotide comprising nucleotide sequence encoding a polypeptide; vectors; use in transforming plant cell |
| 09/23/2003 | US6624288 Conotoxins comprising cyclic peptides used as agonists of calcium channels blockers |
| 09/23/2003 | US6624146 MTS represents a membrane-transfer amino acid sequence; X represents a direct bond or a linker sequence; and NLS represents a nuclear localization amino acid sequence, or a pharmaceutically acceptable salt thereof for weight reduction |
| 09/23/2003 | US6624145 The subject invention concerns new classes of pesticidal toxins and the polynucleotide sequences which encoded these toxins. Also described are novel pesticidal isolates of Bacillus thuringiensis soil microbe Bacillus |
| 09/23/2003 | US6624144 Matrix metalloproteinase inhibitors and down-regulators |
| 09/23/2003 | US6624141 Protamine fragment compositions and methods of use |
| 09/23/2003 | US6624140 Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 09/23/2003 | US6624139 Applying a hypersensitive response elicitor in a non-infectious form to plants or plant seeds under conditions effective to impart stress resistance to plants or plants grown from the plant seeds. Transgenic plants or plant seeds |
| 09/23/2003 | US6623981 Detecting antibodies which bind integrin bound modulators; obtain sample, incubate with modulators and antibodies, form complexes, screen for bound complex |
| 09/23/2003 | US6623980 Mixing polypeptides with exogeneous proteins, oligopeptides, polysaccharides or polynucleotides, then analyzing binding; medical diagnosis and therapy |
| 09/23/2003 | US6623961 Method for selective inactivation of viral replication |
| 09/23/2003 | US6623957 Immunotherapy for T-cell mediated autoimmune disease |
| 09/23/2003 | US6623952 Infectious; of given sequence; may be used as a vector for gene therapy, in a vaccine or for detection of viruses for xenotransplantation |
| 09/23/2003 | US6623951 HBV vectors and cells for producing the same |
| 09/23/2003 | US6623950 Modified enzymes having polymer conjugates |
| 09/23/2003 | US6623942 Nucleotide sequences coding polypetide for use in treatment of hematopoietic and immunological disorders; wound healing agents |
| 09/23/2003 | US6623941 Polynucleotide, of given sequence, encoding a polypeptide; expressed in mature B cells; use in diagnosis and treatment of rheumatoid arthritis, lupus, anemia and inflammation |
| 09/23/2003 | US6623940 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 09/23/2003 | US6623939 Nucleic acids encoding a G protein gamma subunit involved in sensory transduction |